Edgewood Oncology
Brookline
About Edgewood Oncology
Edgewood Oncology is a clinical-stage biotechnology business established to fulfill the potential of BTX-A51 for patients with solid tumors that are genetically specified and hematologic malignancies. Our goal is to create a novel treatment that will prolong and enhance the lives of those with the greatest unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $20.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2024)
- Website: edgewoodoncology.com
- Phone: (508) 281-9912
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/edgewood-oncology-43666 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.